Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/08/2022* -- Results Q3 2022 -- -0.13 --
11/08/2021 -- Results Q3 2021 -0.11 -0.12 7.80%
08/09/2021 -- Results Q2 2021 -0.13 -0.11 -15.91%
04/29/2021 -- Results Q1 2021 -0.24 -0.22 -9.09%
03/01/2021 -- Results Q4 2020 -0.22 -0.21 -4.76%
10/29/2020 -- Results Q3 2020 -0.21 -0.23 8.70%
08/04/2020 -- Results Q2 2020 -0.24 -0.40 40.00%
04/30/2020 -- Results Q1 2020 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/08/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/08/2021
Beat/Miss Upgrade
Return Since -46.93%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases.
URL https://www.iderapharma.com
Investor Relations URL http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
HQ State/Province Pennsylvania
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Nov. 08, 2022 (est.)
Last Earnings Release Nov. 08, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio --
Cash Payout Ratio --
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-29.93%
-51.46%
40.67%
-83.59%
-34.30%
101.6%
-84.47%
-19.68%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-9.34%
-60.95%
-43.90%
-20.43%
-35.52%
-81.84%
-47.97%
-70.67%
-67.38%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-16.15%
-44.57%
-56.37%
48.58%
-52.96%
5.47%
10.67%
-77.09%
47.29%
-61.17%
-88.94%
-77.05%
-79.57%
12.53%
-8.16%
83.59%
-22.99%
As of August 12, 2022.

Profile

Edit
Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases.
URL https://www.iderapharma.com
Investor Relations URL http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
HQ State/Province Pennsylvania
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Nov. 08, 2022 (est.)
Last Earnings Release Nov. 08, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter IDRA Tweets